Brief: Achilles Therapeutics Reports Fourth Quarter And Year-End 2021 Financial Results And Recent Business Highlights

Achilles Therapeutics

01/03/2022 12:36

March 1 (Reuters) - Achilles Therapeutics PLC  698y.F :
    * ACHILLES THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END
2021
FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * PATIENT DATA FROM HIGHER DOSE CNET AS MONOTHERAPY AND CNET
IN
COMBINATION WITH CHECKPOINT INHIBITOR EXPECTED IN 2H 2022
    * STRONG CASH POSITION OF $266 MILLION SUPPORTS CLINICAL
DEVELOPMENT AND MANUFACTURING EXPANSION INTO 2H 2024
    * Q4 LOSS PER SHARE $0.45
    * CASH AND CASH EQUIVALENTS WERE $266.3 MILLION AS OF
DECEMBER 31,
2021

Source text for Eikon:  ID:nGNX8VNqXm 
Further company coverage:  698y.F 

 ((Reuters.Briefs@thomsonreuters.com;))